Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olwyn M.R. Westwood is active.

Publication


Featured researches published by Olwyn M.R. Westwood.


Clinical medicine insights. Arthritis and musculoskeletal disorders | 2008

Comparison of Antigenic Regions Identified on IgG1Fc Using Bioinformatics vs Pepscan Analysis

Paul N. Nelson; Olwyn M.R. Westwood; Graham L. Freimanis; Denise A. Roden; Samir Sissaoui; Paul Rylance; Frank C. Hay

Epitope mapping allowed the location of antigenic determinants on a protein macromolecule to be identified. In particular, pepscan techniques that utilize a series of overlapping peptides, help detect key amino acid residues that are important in antibody recognition and binding. In a previous study, we employed 15-mer peptides spanning the entire length of IgG1Fc to ascertain successfully the target epitopes of isotypic/allotypic monoclonal reagents. As an extension to this work we have used these peptides to evaluate the location of epitope targets of five IgM rheumatoid factor antibodies (RFAbs). Overall, 2 antibodies, RFAb TS2 and TS1, detected a similar epitope within the CH3 domain (360-KNQVSLTCLVKGFYP-374), whilst 1 (RFAb SJ1) recognised an epitope in the CH2 domain (294-EQYNSTYRVVSVLTV-308). In contrast, 2 RFAbs, PRSJ2 and PRTS1 detected four and five epitopes respectively within the Fc region. RFAb PRSJ2 recognised epitopes detected by RFAB TS2 and TS1 but also further epitopes in the CH2 domain (256-TPEVTCVVVDVSHED-270) and CH3 domain (418-QQGNVFSCSVMHEAL-432). Similarly, RFAb PRTS1 detected all four epitopes plus a fifth in the CH3 domain (382-ESNGQPENNYKTTPP-396). In essence there was a consensus of target epitopes identified by these rheumatoid factor antibodies. Interestingly, two epitopes (256–270, CH2 domain and 360–374, CH3 domain) were novel in that they had not been identified in previous pepscan studies. The other epitopes recognised, either overlapped or were immediately adjacent to previous epitopes detected by poly/monoclonal rheumatoid factor antibodies. Molecular modelling (PCImdad) of IgG1Fc showed that all five epitopes were exposed and surface accessible for antibody interaction. In addition, a bioinformatics analysis of the Fc region using ExPASy was employed to identify key antigenic determinants. This ‘in silico’ approach may provide a means of determining key regions without the need to develop overlapping peptides spanning the entire length of a macromolecule.


Cytotechnology | 1993

Changes in levels of pancreatic endoplasmic reticulum proteins that function in translocation and maturation of secretory proteins in response to cholecystokinin.

Andrew Robinson; Mingyue He; Olwyn M.R. Westwood; Brian M. Austen

Two pathways operate to target newly-synthesised proteins to the endoplasmic reticulum. In one, the signal recognition particle attaches to the signal sequences of nascent chains on ribosomes and slows or stops translation until contact is made with the docking protein at the membrane. The second operates via molecular chaperons. The pathways converge at the level of a 43 kDa signal binding protein integrated into the membrane, where translocation through a proteinaceous pore is initiated. In the lumen, proteins fold and disulphide formation is catalysed by the enzyme protein disulphide isomerase. The heavy chain binding protein may attach to unassembled or unfolded proteins and prevent their exit from the ER to the Golgi. Cholecystokinin (CCK) treatment increases the biosynthesis and secretion of pancreatic proteins, increases the levels of PDI and the 43 kDa binding protein, and reduces levels of BiP. These proteins may be possible targets for genetic manipulation to improve processing of heterologous proteins from cultured mammalian cells.


Archive | 1993

CROSS-LINKING SIGNAL SEQUENCES TO COMPONENTS OF YEAST MICROSOMES.

Olwyn M.R. Westwood; Brian M. Austen

Candidate proteins of the endoplasmic reticulum (ER) membrane functional in the translocation of newly-synthesised proteins from the cytoplasm to the lumen have been identified using cross-linking to photoreactive truncated nascent polypeptides paused in the act of translocation. Proteins include SSRalpha, a glycoprotein of 34kDa Mr (Weidmann et al, 1987), which has one transmembrane region and is part of a heterotetrameric complex, while a glycoprotein of 36kDa, translocating chain-associated membrane protein (TRAM), is cross-linked in reconstituted proteoliposomes to a translocation intermediate with carbodiimide. TRAM is predicted to cross the membrane eight times (Gorlich et al., 1992).


Archive | 2000

Epitope mapping : a practical approach

Olwyn M.R. Westwood; Frank C. Hay


Rheumatology | 2006

Rheumatoid factors: what's new?

Olwyn M.R. Westwood; Paul N. Nelson; Frank C. Hay


Archive | 1991

Protein targeting and secretion

Brian M. Austen; Olwyn M.R. Westwood


Archive | 2008

Phagocytosis, Complement and Antibody‐dependent Cytotoxicity

Frank C. Hay; Olwyn M.R. Westwood


Archive | 2008

Immunological Manipulations in vivo

Frank C. Hay; Olwyn M.R. Westwood


Archive | 2008

Isolation and Structure of Immunoglobulins

Frank C. Hay; Olwyn M.R. Westwood


Biochemical Journal | 1990

Interactions of signal peptides with signal-recognition particle.

Andrew Robinson; Olwyn M.R. Westwood; Brian M. Austen

Collaboration


Dive into the Olwyn M.R. Westwood's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul N. Nelson

University of Wolverhampton

View shared research outputs
Top Co-Authors

Avatar

Denise A. Roden

University of Wolverhampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian M. Adcock

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge